7 different technologies are being used to develop a COVID-19 vaccine in Thailand, with the most advanced being the mRNA, DNA, and protein subunit.
A vaccine is not likely to eradicate the virus, the advisor cautioned.
Meanwhile, Prof. Jonathan Van Tam, the deputy CMO of England commented that AstraZeneca's COVID-19 vaccine could be ready for a mass roll-out as early as December.
However, rolling out such a vaccine to people is subject to regulatory approval.
The government said it would invest £33.6 million in the studies in partnership with Imperial College London, laboratory and trial services company hVIVO and the Royal Free London NHS Foundation Trust.
"So let me be clear, assuming positive data, Pfizer will apply for Emergency Authorization Use in the U.S. soon after the safety milestone is achieved in the third week of November", wrote Bourla. In addition to saving time, early purchase of syringes and safety boxes also reduces pressure on the market and pre-empts potential early spikes in demand when vaccines do become available.
If the vaccine doesn't demonstrate sufficient efficacy at the first interim analysis, the company will conduct a second analysis when 106 cases of symptomatic Covid-19 occur.
"Unlike sometimes when you make a recipe at home, if you miss one ingredient, you might decide to still go ahead and make your meal, but in our case we can not do that", Mr. Bancel said.
'It shows the public that this is how FDA is going about its decisions, ' Jason Schwartz, an assistant professor of health policy and management at the Yale School of Public Health, who is not on the committe, told STAT News.
"It would be a mistake not to be aware of the way that the CDC and the FDA have been pressured by the White House, no matter who's in the White House", said David Magnus, director of the Stanford Center for Biomedical Ethics, so "it might be prudent for a state to make sure everything's kosher". It's not the president driving the train, but it's these processes, these very technical and sometimes dry processes that will be driving the review of vaccines in the months ahead'.
Recently, Deputy Prime Minister and Minister of Public Health Anutin Charnvirakul signed a letter of intent for the production and allocation of a research vaccine against Covid-19 with the University of Oxford. Almost 200 are in different phases of development and testing and a dozen are in the last phase of the process before an assessment and possible authorization by health authorities, according to figures from the World Health Organization.